IP Library Granted Patent US 8,275,451
Granted Patent B2
US 8,275,451 · App. 11/140,057 · Granted Sep 25, 2012

Maternal-fetal monitoring system

Assignees: University of Florida Research Foundation, Inc.; Convergent Engineering, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,275,451
App. No.
11/140,057
Granted
Sep 25, 2012
Kind
B2
Abstract

A maternal-fetal monitoring system for use during all stages of pregnancy, including antepartum and intrapartum stages. The maternal-fetal monitoring system of the subject invention comprises (1) a set of sensors; (2) an amplifying/filtering means; (3) a computing means; and (4) a graphical user interface. Accurate clinical data, which can be extracted and provided to the user in real-time using the system of the invention, include without limitation, maternal electrocardiogram (ECG) signals, maternal uterine activity signals (EHG), maternal heart rate, fetal ECG signals, and fetal heart rate. In a preferred embodiment, the maternal-fetal monitoring system of the invention includes an intelligence means, such as a neural network system, to analyze and interpret clinical data for use in clinical diagnosis antepartum, intrapartum and postpartum, as well as delivery strategy.

Claims (22)

1. A maternal-fetal monitoring system comprising:

a) at least two surface sensors to receive a mixture of maternal and fetal vital signals, wherein the mixture of maternal and fetal vital signals comprises at least one EHG signal; and

b) a computing means for analyzing the mixture of maternal and fetal vital signals from the sensors, said computing means including hardware and software, wherein said software comprises a means for converting the at least one EHG signal directly into montevideo units without first calculating an intrauterine pressure curve.

2. The maternal-fetal monitoring system of claim 1 , wherein said computing means comprises a neural network system.

3. The maternal-fetal monitoring system of claim 1 , wherein the at least one EHG signal has a frequency in a range of 0.16 Hz to 100 Hz.

4. A maternal-fetal monitoring system comprising:

a) at least two surface sensors to receive a mixture of maternal and fetal vital signals; and

b) a computing means for analyzing the mixture of maternal and fetal vital signals from the sensors, said computing means including hardware and software, wherein said software comprises a means for extracting EHG to provide at least one EHG spectrogram having at least one characteristic;

wherein said characteristic is associated with a feature selected from the group consisting of contraction efficiency, probability of vaginal delivery, time to delivery, arrested descent, the effectiveness of drugs used to induce labor, uterine rupture, and post-delivery maternal uterine tone.

5. The maternal-fetal monitoring system of claim 4 , wherein said software means further comprises an analyzing means for identifying in the EHG spectrogram said special characteristic and for providing said analysis with regard to said feature to the user.

6. The maternal-fetal monitoring system of claim 4 , further comprising a sensor to receive abdominal muscle signals; wherein said software means further comprises a biofeedback means for directing maternal pushing efforts during labor.

7. The maternal-fetal monitoring system of claim 4 , wherein said characteristic is associated with a feature selected from the group consisting of contraction efficiency and the effectiveness of drugs used to induce labor.

8. The maternal-fetal monitoring system of claim 7 , wherein said characteristic is associated with contraction efficiency.

9. The maternal-fetal monitoring system of claim 7 , wherein said characteristic is associated with the effectiveness of drugs used to induce labor.

10. The maternal-fetal monitoring system of claim 4 , wherein said characteristic is associated with probability of vaginal delivery.

11. The maternal-fetal monitoring system of claim 4 , wherein said characteristic is associated with time to delivery.

12. The maternal-fetal monitoring system of claim 4 , wherein said characteristic is associated with arrested descent.

13. The maternal-fetal monitoring system of claim 4 , wherein said characteristic is associated with uterine rupture.

14. The maternal-fetal monitoring system of claim 4 , wherein said characteristic is associated with post-delivery maternal uterine tone.

15. The maternal-fetal monitoring system of claim 4 , wherein the EHG spectrogram directly and reliably predicts the feature.

16. The maternal-fetal monitoring system of claim 4 , wherein the EHG signal extracted to provide the at least one EHG spectrogram has a frequency in a range of 0.16 Hz to 100 Hz.

17. The maternal-fetal monitoring system of claim 7 , wherein the EHG signal extracted to provide the at least one EHG spectrogram has a frequency in a range of 0.16 Hz to 100 Hz.

Assignments (4)
SECURITY INTEREST Recorded Feb 18, 2018
From: OBMEDICAL COMPANY
To: STUBBS, JAMES B
Reel/Frame 044962/0966 →
CONFIRMATORY LICENSE Recorded Jun 15, 2015
From: UNIVERSITY OF FLORIDA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 035905/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2012
From: EULIANO, TAMMY Y; PRINCIPE, JOSE C
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 028803/0857 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2005
From: MAROSSERO, DOROTHEE; EULIANO, NEIL RUSSELL II
To: CONVERGENT ENGINEERING, INC.
Reel/Frame 016605/0089 →
Continuity (2)
Continuation In Part 10857107 · May 28, 2004
Related Publication 20050267377A1 · Dec 1, 2005